Great Valley Advisor Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.13M Buy
24,620
+408
+2% +$39.1K 0.04% 358
2025
Q4
$2.33M Buy
24,212
+785
+3% +$76.3K 0.04% 313
2025
Q3
$2.23M Sell
23,427
-1,799
-7% -$165K 0.04% 312
2025
Q2
$2.2M Sell
25,226
-1,916
-7% -$162K 0.05% 297
2025
Q1
$2.44M Sell
27,142
-4,256
-14% -$381K 0.05% 277
2024
Q4
$2.51M Sell
31,398
-58,288
-65% -$5.05M 0.06% 279
2024
Q3
$8.07M Buy
89,686
+5,518
+7% +$464K 0.2% 122
2024
Q2
$6.62M Buy
84,168
+11,789
+16% +$966K 0.19% 127
2024
Q1
$6.31M Sell
72,379
-356
-0.5% -$30.4K 0.19% 125
2023
Q4
$5.99M Sell
72,735
-5,445
-7% -$415K 0.21% 123
2023
Q3
$6.13M Buy
78,180
+7,344
+10% +$615K 0.25% 101
2023
Q2
$6.24M Buy
70,836
+8,021
+13% +$691K 0.26% 100
2023
Q1
$5.06M Buy
62,815
+42,342
+207% +$3.45M 0.24% 109
2022
Q4
$1.59M Sell
20,473
-21,943
-52% -$1.78M 0.08% 248
2022
Q3
$3.42M Sell
42,416
-2,845
-6% -$256K 0.19% 136
2022
Q2
$4.06M Buy
45,261
+5,557
+14% +$563K 0.22% 113
2022
Q1
$4.3M Buy
39,704
+1,165
+3% +$123K 0.25% 102
2021
Q4
$4.26M Buy
38,539
+1,684
+5% +$195K 0.26% 100
2021
Q3
$4.62M Buy
36,855
+1,753
+5% +$227K 0.32% 80
2021
Q2
$4.28M Buy
35,102
+3,471
+11% +$436K 0.32% 80
2021
Q1
$3.74M Sell
31,631
-874
-3% -$102K 0.36% 61
2020
Q4
$3.81M Buy
32,505
+399
+1% +$43.9K 0.39% 57
2020
Q3
$3.34M Buy
32,106
+10,363
+48% +$1.04M 0.41% 59
2020
Q2
$1.99M Buy
21,743
+4,741
+28% +$455K 0.33% 84
2020
Q1
$1.53M Buy
17,002
+260
+2% +$27.7K 0.41% 72
2019
Q4
$1.9M Buy
16,742
+511
+3% +$56.1K 0.42% 72
2019
Q3
$1.76M Buy
16,231
+547
+3% +$57.1K 0.42% 67
2019
Q2
$1.53M Buy
15,684
+11,443
+270% +$1.04M 0.38% 83
2019
Q1
$386K Buy
4,241
+92
+2% +$8.23K 0.12% 185
2018
Q4
$377K Buy
+4,149
New +$388K 0.14% 136

Other funds holding MDT

Great Valley Advisor Group's MDT Position: Q1 2026 in Review

Great Valley Advisor Group increased its Medtronic (MDT) stake by 1.7% in Q1 2026, buying an estimated $39.1K and bringing the position to 24,620 shares worth $2.13M. The position accounts for 0.04% of the portfolio, ranked #358.

Great Valley Advisor Group first reported a position in MDT in Q4 2018 and has held it in 30 quarters since. The position peaked at $8.07M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Great Valley Advisor Group held 24,620 shares of Medtronic worth $2.13M as of Q1 2026.
  • Great Valley Advisor Group bought 408 Medtronic shares in Q1 2026, an estimated $39.1K.
  • Medtronic made up 0.04% of Great Valley Advisor Group's portfolio in Q1 2026, its #358 holding.
  • Great Valley Advisor Group first reported a position in Medtronic in Q4 2018 and has held it in 30 quarters since.
  • Great Valley Advisor Group's Medtronic position peaked at $8.07M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.